AI camera could catch melanoma before It's too late

NCT ID NCT06221397

Completed Diagnosis Sponsor: AI Labs Group S.L Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested whether an artificial intelligence (AI) system can help detect melanoma, a dangerous form of skin cancer. Researchers took photos of suspicious skin spots from 105 adults using a smartphone camera and let the AI analyze them. They compared the AI's results to diagnoses from skin doctors and lab tests. The goal was to see if the AI could match or improve upon expert judgment, without changing the care patients received.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-based Computer-Aided Diagnosis (CAD) software
What this could lead to: If successful, this AI tool could help doctors spot skin cancer earlier and more accurately, potentially saving lives through faster treatment.
What could go wrong: This was a small, completed observational study with 105 participants. The AI's performance may not hold up in larger, more diverse populations or real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CUTANEOUS MELANOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cutaneous melanoma disease melanoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MELANOMA MELANOMA (SKIN)

Contacts and locations

Locations

University Hospital of Cruces

Barakaldo, Biscay, 48903, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.